Granules India Ltd.
Snapshot View

View in App

Prices View details >>

271.00 -13.10 ▼-4.6%

28 March 2023, 04:01:00 PM
Volume: 54,175

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.granulesindia.com
Market Cap 6,559.36 Cr.
Enterprise Value(EV) 7,059.04 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.99 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 12.91 Trailing Twelve Months Ending 2022-12
Industry PE 32.00 Trailing Twelve Months Ending 2022-12
Book Value / Share 112.46 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.41 Calculated using Price: 271.00
Dividend Yield 0.55 Period Ending 2022-03
No. of Shares Subscribed 24.20 Cr. 242,042,756 Shares
FaceValue 1
Company Profile
Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs).

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.61%
1 Week
-6.00%
1 Month
-3.18%
3 Month
-17.45%
6 Month
-14.75%
1 Year
-12.97%
2 Year
-10.00%
5 Year
+161.84%
10 Year
+2758.65%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 24.20 23.29 23.53 18.23 10.60 13.32 18.54 27.64 17.49
Return on Capital Employed (%) 19.90 18.81 20.16 16.57 11.09 12.71 17.22 25.42 17.37
Return on Assets (%) 8.98 8.28 9.03 8.12 5.13 6.64 9.99 15.84 10.04

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 356 431 662 904 1,304 1,529 1,844 2,173 2,587 2,598
Non Curr. Liab. 344 357 247 188 488 553 486 366 283 242
Curr. Liab. 293 415 655 787 878 896 893 1,173 1,642 2,017
Minority Int. 1
Equity & Liab. 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,858
Non Curr. Assets 612 700 745 1,051 1,484 1,696 1,594 1,716 2,007 2,129
Curr. Assets 377 500 818 828 1,187 1,282 1,629 1,997 2,505 2,729
Misc. Exp. not W/O 4 3
Total Assets 992 1,203 1,563 1,879 2,670 2,979 3,223 3,713 4,512 4,858

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,096 1,294 1,357 1,411 1,685 2,279 2,599 3,238 3,765 4,346
Other Income 4 4 6 10 11 27 37 27 18 14
Total Income 1,100 1,297 1,363 1,420 1,695 2,306 2,635 3,264 3,783 4,361
Total Expenditure -938 -1,084 -1,081 -1,112 -1,406 -1,895 -2,073 -2,382 -3,043 -3,468
PBIDT 163 213 282 309 289 411 562 882 740 893
Interest -20 -32 -37 -32 -33 -28 -27 -26 -23 -44
Depreciation -30 -53 -58 -72 -76 -105 -137 -151 -159 -176
Taxation -37 -37 -61 -65 -63 -89 -116 -155 -145 -165
Exceptional Items 28
PAT 75 91 125 140 117 188 310 549 413 508
Minority Interest
Share Associate -2 25 16 49 25
Other Related Items
Consolidated Net Profit 75 91 123 165 133 236 335 549 413 508
Adjusted EPS 4 4 6 7 5 9 13 22 17 21

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 91 108 150 151 188 -1 262 476 432 332
Cash Fr. Inv. -128 -255 -146 -162 -326 -462 -270 -161 -277 -380
Cash Fr. Finan. 46 147 19 86 56 529 -17 -213 -299 190
Net Change 10 0 24 75 -82 66 -25 103 -144 142
Cash & Cash Eqvt 42 42 65 130 42 108 83 186 42 185

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 42.04 42.04 42.04 42.04 41.98 41.98 41.98 41.93 42.02
Public 57.96 57.96 57.96 57.96 58.02 58.02 58.02 58.07 57.98
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 8.64 8.64 6.92 6.92 6.92 6.92 10.59 10.59 4.03

Announcements View Details >>

Tue, 28 Mar 2023
Closure of Trading Window
Closure of Trading Window
Tue, 21 Mar 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Consumer Health Inc. concludes FDA Audit withZero Observations
Fri, 17 Mar 2023
Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr. Robert George Cunard as an Independent Director

Technical Scans View Details >>

Tue, 28 Mar 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,142.55 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. 75,408.82 4,534.70 +1.1%
Divi's Laboratories Ltd. 74,473.23 2,805.35 -0.8%
Cipla Ltd. 71,800.08 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. 62,246.53 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. 52,239.05 1,539.00 +0.3%
Zydus Lifesciences Ltd. 49,031.17 484.40 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.01 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.72 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-12 31.07 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-12 27.21 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 81.27 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.68 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.79 484.40 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.27 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.43 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-12 3.16 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.07 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.84 484.40 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 0.04 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 484.40 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 484.40 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 13.10 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 484.40 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 484.40 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.20 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,534.70 +1.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,805.35 -0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 889.55 +0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,322.00 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,539.00 +0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 484.40 +0.4%

FAQ's On Granules India Ltd.

What is Granules India share price?
Can I buy Granules India shares now?
What is the Dividend Yield of Granules India?
What is the Market Cap of Granules India?
What are the key metrics to analyse Granules India?
What is the 52 Week High and Low of Granules India?
What is the trend of Granules India share price?